US2009326274A1PendingUtilityA1
Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis
Est. expiryNov 17, 2024(expired)· nominal 20-yr term from priority
B01J 2531/845B01J 31/1805B01J 2531/827B01J 2531/822B01J 2531/828B01J 2531/847B01J 2531/824C07C 311/18B01J 2531/821B01J 2231/643C07B 2200/07C07C 29/143B01J 2531/842C07C 2602/10C07B 41/02C07C 311/15C07C 311/16
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A diamine of formula (I) is described in which A is hydrogen or a saturated or unsaturated C1-C20 alkyl group or an aryl group; B is a substituted or unsubstituted C1-C20 alkyl, cycloalkyl, alkaryl, alkaryl or aryl group or an alkylamino group and at least one of X 1 , X 2 , Y 1 , Y 2 or Z is a C1-C10 alkyl, cycloalkyl, alkaryl, aralkyl or alkoxy substituting group. The chiral diamine may be used to prepare catalysts suitable for use in transfer hydrogenation reactions.
Claims
exact text as granted — not AI-modified1 . A diamine of formula (I)
in which A is hydrogen or a saturated or unsaturated C1-C20 alkyl group or an aryl group; B is a substituted or unsubstituted C1-C20 alkyl, cycloalkyl, alkaryl, alkaryl or aryl group or an alkylamino group and at least one of X 1 , X 2 , Y 1 , Y 2 or Z is a C1-C10 alkyl, cycloalkyl, alkaryl, aralkyl or alkoxy substituting group.
2 . The diamine according to claim 1 wherein A is hydrogen.
3 . The diamine according to claim 1 wherein B is a substituted or unsubstituted aryl group.
4 . The diamine according to claim 1 wherein X 1 , X 2 , Y 1 and Y 2 are hydrogen and Z is a C1-C10 alkyl, alkaryl, cycloalkyl, aralkyl or alkoxy substituting group.
5 . The diamine according to claim 4 wherein Z is methyl.
6 . The diamine according to claim 4 wherein Z is methoxy.
7 . The diamine according to claim 1 wherein the diamine is homochiral.
8 . The method for preparing a diamine of formula (I) as claimed in claim 1 comprising the steps of
a) forming a substituted spiroimidazole from a substituted diketone of formula (II), b) reducing the substituted spiroimidazole to form a substituted diamine, c) optionally resolving the substituted diamine to an enantiomerically enriched form, and d) sulphonylating the substituted diamine.
9 . A catalyst comprising the reaction product of a diamine of formula (I) as claimed in claim 1 and a compound of a metal selected from the list consisting of Ru, Rh, Ir, Co, Ni, Fe, Pd or Pt.
10 . The catalyst according to claim 9 wherein the metal compound is [MX 2 (arene)] 2 where M=Rh or Ru and X=halogen.
11 . A method comprising contacting the catalyst according to claim 9 with a compound and performing a transfer hydrogenation reaction.
12 . The method according to claim 11 wherein the compound is a cyclic ketone.
13 . The diamine according to claim 2 wherein B is a substituted or unsubstituted aryl group.
14 . The diamine according to claim 2 wherein X 1 , X 2 , Y 1 , and Y 2 are hydrogen and Z is a C1-C10 alkyl, alkaryl, cycloalkyl, aralkyl or alkoxy substituting group.
15 . The diamine according to claim 3 wherein X 1 , X 2 , Y 1 and Y 2 are hydrogen and Z is a C1-C10 alkyl, alkaryl, cycloalkyl, aralkyl or alkoxy substituting group.
16 . The diamine according to claim 13 wherein X 1 , X 2 , Y 1 and Y 2 are hydrogen and Z is a C1-C10 alkyl, alkaryl, cycloalkyl, aralkyl or alkoxy substituting group.
17 . The diamine according to claim 14 wherein Z is methyl or methoxy.
18 . The diamine according to claim 15 wherein Z is methyl or methoxy.
19 . The diamine according to claim 16 wherein Z is methyl or methoxy.
20 . The diamine according to claim 19 wherein the diamine is homochiral.Join the waitlist — get patent alerts
Track US2009326274A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.